Global Artificial Blood Substitutes Market is Growing with a CAGR of 25.6% in the Forecast Period of 2021 to 2028

Global Artificial Blood Substitutes Market is growing with factors such as limited availability of fresh blood and its short life span. The increasing demand for blood transfusion and increased funding for development of blood substitutes as a major factor for the growth of the market.

Technological advancements have propelled the demand of the market. However, the high cost production of artificial blood as well as stringent rules laid down by governmental bodies for approval of blood substitute products has decreased the demand of the market.

Global Artificial Blood Substitutes Market Scenario                  

According to Data Bridge Market Research, the market for global artificial blood substitutes in North America has the highest market share followed by Europe and Middle East & Africa. Market leader is Kalocyte, Inc., which accounts an estimated market share of approximately 19.60% in the global market. The company has gained funding for research and development of artificial blood substitutes.

  • In June 2020, KaloCyte, Inc. received a USD 300k funding from University System of Maryland (USM) Momentum Fund for developing ErythroMer, a synthetic, bio-inspired red blood substitute. This funding has helped the company in developing the ErythroMer at much faster pace.

Artificial Blood Substitutes MarketTrends Impacting the Market

Now the question is which other regions KaloCyte, Inc., HEMARINA, Hemoglobin Oxygen Therapeutics LLC are targeting? Data Bridge Market Research has forecasted a large growth in North America artificial blood substitutes market and the market leaders targeting U.S. and Mexico to be their next pocket revenue for 2021.

The artificial blood substitutes market is becoming more competitive with companies like KaloCyte, Inc., HEMARINA, Hemoglobin Oxygen Therapeutics LLC. These are the top dominating companies in artificial blood substitutes market and have launched novel software, services and consumables in the market. The data bridge market research new reports highlight the major growth factors and opportunities in the global artificial blood substitutes market.

For more analysis on the global artificial blood substitutes market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-artificial-blood-substitutes-market

Artificial blood substitutes Market Developments

  • In November 2020, Hemarina published a scientific report for anti-inflammatory and antibacterial property of M 101, an oxygen transporter for the treatment of periodontitis. This study has validated the quality of M 101 molecolue, which is derived from haemoglobin of the marine lugworm.
  • In April 2019, Hemoglobin Oxygen Therapeutics LLC announced the publication of its preclinical data which demonstrated that the Hempure could replace packed red blood cells (RBCs) in normothermic kidney perfusion (NMP). This announcement helped the company in gaining significant intrest in the organ transplantation field.
  • In June 2020, KaloCyte, Inc. received a USD 300k funding from University System of Maryland (USM) Momentum Fund for developing ErythroMer, a synthetic, bio-inspired red blood substitute. This funding has helped the company in developing the ErythroMer at much faster pace.

Scope of the Artificial blood substitutes Market

Global Artificial Blood Substitutes Market, By Product Type (Perflurocarbon (PFCs) and Hemoglobin-Based Oxygen Carries (HBOCs)), Source (Human Blood, Animal Blood, Microorganism Based Recombinant HB, Synthetic Polymers and Stem Cells), Application (Cardiovascular Diseases, Malignant Neoplasma, Injuries, Neonatal Conditions, Organ Transplant and Maternal Condition), End User (Hospital & Clinics, Blood Banks and Others), Country (U.S., Mexico, France, Russia, Netherlands, Rest of Europe, China, Rest of Asia-Pacific, South Africa, and Rest of Middle East and Africa) Industry Trends and Forecast To 2028

All country based analysis of the global artificial blood substitutes market is further analysed based on maximum granularity into further segmentation. On the basis of product type, the global artificial blood substitutes market is segmented into perflurocarbon (PFCs) and hemoglobin-based oxygen carries (HBOCs). On the basis of source, the global artificial blood substitutes market is segmented into human blood, animal blood, microorganism based recombinant HB, synthetic polymers and stem cells. On the basis of application, the global artificial blood substitutes market is segmented into cardiovascular diseases, malignant neoplasma, injuries, neonatal conditions, organ transplant and maternal condition. On the basis of end user, the global artificial blood substitutes market is segmented into hospital & clinics, blood banks and others.

To know more about the study https://www.databridgemarketresearch.com/reports/global-artificial-blood-substitutes-market

Key Pointers Covered in Artificial blood substitutes Market Industry Trends and Forecast to 2028

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries
  • Market value and over view of Artificial blood substitutes market
  • Company profiling of top eight players of Artificial blood substitutes market

Key Market Competitors Covered in the Report

  • HEMARINA
  • Hemoglobin Oxygen Therapeutics LLC
  • KaloCyte, Inc.
  • LLC “Visusmed”
  • European Medicines Agency
  • OPK Biotech LLC
  • NuvOx Pharma
  • Prolong Pharmaceuticals, LLC
  • Boston Therapeutics, Inc.
  • Aurum Biosciences
  • OXYVITA Inc
  • NanoBlood LLC

Above are the key players covered in the report, to know about more and exhaustive list of artificial blood substitutes companies’, contact us https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-artificial-blood-substitutes-market

Research Methodology: Global Artificial blood substitutes Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Manufacturer, Scientists, Research Laboratories
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/